– Novimmune Sa

7 email addresses found for novimmune.com
{first}-{last}@novimmune.com
7 email addresses
http://acquisition-intl.com/2016-mid-market-top-50 May 5, 2017
http://aravis.asia/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders January 1, 2017
http://aravis.ch/news June 6, 2018
http://aravis.ch/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders March 3, 2016
http://aravis.dk/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders November 11, 2017
http://aravis-energy.com/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders April 4, 2018
http://aravisenergy.com/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders May 5, 2018
http://aravis.info/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders January 1, 2017
http://aravis.ky/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders April 4, 2018
http://aravispartners.ch/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders January 1, 2017
http://aravisventures.com/news/2016/01/novimmune-completes-chf30-million-29-8-million-funding-round-with-existing-shareholders April 4, 2018
http://bioportfolio.com/news/article/3665200/tg-therapeutics-and-novimmune-sa-announce-global-agreement-for-development-and-commercialization.html June 6, 2018
http://news.cision.com/popular-releases July 7, 2018
http://novimmune.com/en/swiss-biopharmaceutical-company/news/2018/novimmune-submits-biologics-license-application-us-its-lead-drug-emapalumab.html April 4, 2018
http://aravis.asia/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis January 1, 2017
http://aravis.ch/news October 10, 2017
http://aravis.ch/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis March 3, 2017
http://aravis.dk/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis January 1, 2017
http://aravis-energy.com/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis April 4, 2018
http://aravisenergy.com/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis May 5, 2018
http://aravis.info/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis January 1, 2017
http://aravis.ky/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis April 4, 2018
http://aravispartners.ch/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis January 1, 2017
http://aravisventures.com/news/2016/12/novimmune-grants-genentech-an-exclusive-option-to-license-ni-0101-its-anti-tlr4-monoclonal-antibody-for-the-treatment-of-rheumatoid-arthritis April 4, 2018
http://biospace.com/article/releases/shire-expands-broad-monoclonal-antibody-research-platform-enters-license-agreement-for-novimmune-sa-bi-specific-antibody- November 11, 2017
http://biospace.com/news/shire-expands-broad-monoclonal-antibody-research/463335 September 9, 2017
http://legochembio.com/eng March 3, 2017
http://life-sciences-europe.com/news/novimmune-licenses-bispecific-hemophilia-shire-plc-lse-shp-2001-111034.html August 8, 2017
http://life-sciences-europe.com/news/novimmune-opens-branch-office-basel-2017-west-europe-2001-111040.html September 9, 2017
http://life-sciences-germany.com/news/novimmune-legochem-enter-adc-biosciences-inc-kosdaq-141080-2001-109952.html March 3, 2017
http://life-sciences-germany.com/news/novimmune-option-license-tlr4-biodd-genentech-inc-roche-2001-109585.html January 1, 2017
http://news.cision.com/popular-releases July 7, 2018
http://novimmune.com/en/media-investors.html February 2, 2017
http://novimmune.com/en/swiss-biopharmaceutical-company/news/2016/novimmune-appoints-global-head-project-management.html February 2, 2017
http://novimmune.com/en/swiss-biopharmaceutical-company/news/2016/novimmune-broadens-senior-management-team.html February 2, 2017
http://novimmune.com/en/swiss-biopharmaceutical-company/news/2016/novimmune-grants-genentech-exclusive-option-license-ni-0101-its-anti-tlr4-monoclonal-antibody-treatment-rheumatoid-arthritis.html February 2, 2017
http://novimmune.com/en/swiss-biopharmaceutical-company/news/2017/novimmune-grants-tiziana-exclusive-license-ni-1201-anti-il-6r-monoclonal-antibody-treatment-autoimmune-and-inflammatory-diseases.html February 2, 2017
http://shire.com/en/newsroom/2017/july/ne5dqo September 9, 2017
http://shire.com/newsroom/2017/july/ne5dqo March 3, 2018
Show more results

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about novimmune.com

Language of the website: English

Main technology used: